Z

Zortrax SA
WSE:ZRX

Watchlist Manager
Zortrax SA
WSE:ZRX
Watchlist
Price: 0.07 PLN 6.06% Market Closed
Market Cap: zł15.4m

EV/GP

8.7
Current
75%
More Expensive
vs 3-y average of 5

Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.

EV/GP
8.7
=
Enterprise Value
zł14.1m
/
Gross Profit
zł2.1m

Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.

EV/GP
8.7
=
Enterprise Value
zł14.1m
/
Gross Profit
zł2.1m

Valuation Scenarios

Zortrax SA is trading above its 3-year average

If EV/GP returns to its 3-Year Average (5), the stock would be worth zł0.04 (43% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-49%
Maximum Upside
No Upside Scenarios
Average Downside
35%
Scenario EV/GP Value Implied Price Upside/Downside
Current Multiple 8.7 zł0.07
0%
3-Year Average 5 zł0.04
-43%
5-Year Average 5.4 zł0.04
-39%
Industry Average 7.8 zł0.06
-11%
Country Average 4.5 zł0.04
-49%

Forward EV/GP
Today’s price vs future gross profit

Not enough data available to calculate forward EV/GP

Peer Comparison

All Multiples
EV/GP
P/E
All Countries
Close

Market Distribution

Higher than 75% of companies in Poland
Percentile
75th
Based on 347 companies
75th percentile
8.7
Low
0.2 — 2.6
Typical Range
2.6 — 7.5
High
7.5 —
Distribution Statistics
Poland
Min 0.2
30th Percentile 2.6
Median 4.5
70th Percentile 7.5
Max 4 440.2

Zortrax SA
Glance View

Market Cap
15.4m PLN
Industry
Technology

Zortrax SA engages in the provision of 3D printing solutions and services. The company is headquartered in Olsztyn, Woj. Warminsko - Mazurskie. The company went IPO on 2015-04-20. The firm's business clients are public and private medical centers in Poland and the main product are intraocular lenses, which are used by doctors in cataract surgery. Other Company's products include surgical sets and disposable tools, viscoelastics and diagnostic equipment, also used by ophthalmologists during cataract surgery.

ZRX Intrinsic Value
0.04 PLN
Overvaluation 41%
Intrinsic Value
Price zł0.07
Z
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett